Clinical Trial: Adebrelimab in Combination with Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer：A Single-Arm, Multicenter, Exploratory Study (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Adebrelimab in Combination with Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer：A Single-Arm, Multicenter, Exploratory Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132818

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304312

Published by HT Digital Content Services with permission from Health Daily Digest....